Michael Celano
2017 - Recro Pharma
In 2017, Michael Celano earned a total compensation of $978.9K as Chief Operating Officer at Recro Pharma, a 16% decrease compared to previous year.
Compensation breakdown
| Bonus | $28,910 |
|---|---|
| Non-Equity Incentive Plan | $144,850 |
| Option Awards | $188,666 |
| Salary | $362,124 |
| Stock Awards | $231,628 |
| Other | $22,719 |
| Total | $978,897 |
Celano received $362.1K in salary, accounting for 37% of the total pay in 2017.
Celano also received $28.9K in bonus, $144.9K in non-equity incentive plan, $188.7K in option awards, $231.6K in stock awards and $22.7K in other compensation.
Rankings
In 2017, Michael Celano's compensation ranked 9,085th out of 14,666 executives tracked by ExecPay. In other words, Celano earned more than 38.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,085 out of 14,666 | 38th |
Division Manufacturing | 3,476 out of 5,768 | 40th |
Major group Chemicals And Allied Products | 1,190 out of 2,074 | 43rd |
Industry group Drugs | 953 out of 1,730 | 45th |
Industry Pharmaceutical Preparations | 746 out of 1,329 | 44th |
Source: SEC filing on March 23, 2018.
Celano's colleagues
We found two more compensation records of executives who worked with Michael Celano at Recro Pharma in 2017.